COVID-19 Treatment Guidelines

“Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19

Ivermectin

• Dosing Regimens. The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days
• Adverse Events. Generally well tolerated”